Navigation Links
MedeAnalytics Selects Ping Zhang as Senior Vice President of Product Innovation and Chief Technology Officer
Date:4/8/2013

EMERYVILLE, Calif., April 8, 2013 /PRNewswire/ -- MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Ping Zhang , Ph.D. has been appointed senior vice president of product innovation and chief technology officer.

(Logo: http://photos.prnewswire.com/prnh/20100621/SF23660LOGO)

Dr. Zhang has provided engineering leadership for a wide variety of organizations, ranging from startups to some of the world's best-known technology companies. Most recently, he was the senior vice president of research & development for Epocrates, Inc., a mobile and cloud-based health pioneer widely recognized for developing the most popular point-of-care medical applications used by physicians. Prior to Epocrates, he held executive leadership positions for Harris Corporation, Carefx Corporation, QuadraMed Corporation, and Siemens.

"We are delighted to have someone of Ping's caliber join MedeAnalytics at this important time," said MedeAnalytics Chief Executive Officer Mike Gallagher . "We look forward to benefiting from his extensive experience in healthcare, technology, mobility and product innovation to drive our future development efforts."

"MedeAnalytics has a well-deserved reputation for having a world-class and cloud-based analytics platform dedicated to healthcare providers and payers," said Zhang. "I am very excited to be part of such a leading organization, helping make a difference in transforming healthcare."

Zhang earned his bachelor's degree at the age of 19 in China. He holds both a Master of Science degree and a Ph.D. degree from the University of Arkansas at Fayetteville.

About MedeAnalytics
Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.For more information:

MedeAnalytics, Inc.Gary Summers

5858 Horton Street, Suite 475 Lewis & Summers Public Relations

Emeryville, CA 94608 (925) 954-8187gary@prwebsite.com
'/>"/>

SOURCE MedeAnalytics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Baptist Health Selects MedeAnalytics Patient Access Intelligence and Revenue Cycle Intelligence Solutions
2. MedeAnalytics Receives Leadership Award from Ventana Research
3. Angeion Selects Hendrik Struik for Board of Directors
4. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
5. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
6. ZyDoc Selects Health Fidelitys REVEAL™ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
7. Pokagon Band of Potawatomi selects iSALUS Healthcares OfficeEMR™ Solution
8. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
9. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
10. Transonic Systems Selects Infinity Info Systems To Implement Microsoft Dynamics CRM To Drive Business Performance And Operational Excellence
11. The Jewish Hospital - Mercy Health Selects Remedy Informatics ComprehensiveBMT Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ORLANDO, Fla. , Feb. 18, 2017 ... that positive Phase 1 clinical data for Nektar,s lead ... (RCC) were presented at ASCO GU 2017.  NKTR-214 is ... T cells and Natural Killer (NK) cell abundance directly ... on these immune cells.  The results were presented by ...
(Date:2/17/2017)... 17, 2017 Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, ... global ablation technologies market is expected to grow at a CAGR ... market is expected to grow at a CAGR of 9.5% from ... and $9.05bn in 2026. ... How this report will benefit you Read on to ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology:
(Date:2/17/2017)... , ... February 17, 2017 , ... ... and financial planning assistance to families and business owners in and around the ... charity drive to help prevent all forms of domestic violence. , There are ...
(Date:2/16/2017)... New York, New York (PRWEB) , ... February ... ... hard work and determination. After what took over 10 years of research, development ... disruptive technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ...
(Date:2/16/2017)... , ... February 17, 2017 , ... Teaching nursing care ... program, now in development. ACE.P (pediatrics) is being created with the support of the ... of Vulnerable Populations , ACE.P will address what has been identified as a critical ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
(Date:2/16/2017)... Arizona (PRWEB) , ... February 16, 2017 , ... ... (623) 242-5247, doegedevelopment.com/contact/ , doegedevelopment.com , David A Doege is ... company specializing in commercial tenant improvements, ground up new builds, design build, and ...
Breaking Medicine News(10 mins):